January 1, 1996American Journal of Nephrology
Role of Hypertension in Coronary Artery Disease
Population
Patients with hypertension
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May warrant multifactorial hypertension management beyond BP control; leaves open whether vascular-targeted therapies reduce coronary events.
Key Points
- To outline a multifactorial coronary hypothesis explaining why standard blood pressure reduction alone provides limited protection against coronary artery disease.
- Conceptual review analyzing the pathophysiological intersection between hypertension, vascular proliferation, and coronary heart disease.
- Evaluation of a three-component coronary hypothesis across distinct age cohorts and vascular disease stages.
- Traditional blood pressure-lowering therapies fail to meaningfully reduce coronary events because hypertension is a complex syndrome involving inherited metabolic and cardiovascular abnormalities.
- Vascular pathology is driven by three distinct factors: intrinsic vascular wall proliferation and hypertrophy, concomitant atherosclerotic risk factors, and acute hemodynamic destabilization.
- Treating hemodynamic variability effectively lowers acute vascular endpoints in elderly patients with advanced vascular changes, while younger patients require broader therapeutic targeting of vascular proliferation and metabolic risks.
Structured PICO
P
Population
Patients with hypertension
I
Intervention
Antihypertensive therapy and comprehensive risk factor management
Hypertension treatment must extend beyond blood pressure control to include management of metabolic and vascular abnormalities to effectively prevent coronary artery disease.
Cite This Study
Michael A. Weber (1996) studied this question.